Physician profile
Richard A Miller
NPI 1720062938
$6,527.95
in general payments reported to CMS, 2019-2025
39 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $791 · 2021: $1,739 · 2022: $776 · 2023: $1,176 · 2024: $721 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,063.67 | 2020-2025 | |
| Novo Nordisk INC | $954.38 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $608.35 | 2019-2025 | Otezla, Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $490.20 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $372.85 | 2019-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $321.14 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Biohaven Pharmaceuticals, INC. | $269.70 | 2020-2021 | |
| Esperion Therapeutics, INC. | $224.90 | 2020-2021 | |
| Pfizer INC. | $198.47 | 2019-2024 | |
| Astellas Pharma US INC | $187.97 | 2019-2024 | Veozah |
| Allergan, INC. | $172.48 | 2019-2020 | |
| Abbott Laboratories | $162.45 | 2021-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $154.95 | 2022-2023 | |
| Inspire Medical Systems, INC. | $148.72 | 2023-2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $145.36 | 2019-2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.